NL7904755A - PHENYLPIPERAZINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND USE OF THIS DERIVATIVE IN A PHARMA-CEUTIC PRODUCT. - Google Patents

PHENYLPIPERAZINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND USE OF THIS DERIVATIVE IN A PHARMA-CEUTIC PRODUCT.

Info

Publication number
NL7904755A
NL7904755A NL7904755A NL7904755A NL7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A NL 7904755 A NL7904755 A NL 7904755A
Authority
NL
Netherlands
Prior art keywords
ceutic
pharma
derivative
preparation
product
Prior art date
Application number
NL7904755A
Other languages
Dutch (nl)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7818352A external-priority patent/FR2429216A1/en
Priority claimed from FR7818351A external-priority patent/FR2429212A1/en
Application filed by Synthelabo filed Critical Synthelabo
Publication of NL7904755A publication Critical patent/NL7904755A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7904755A 1978-06-20 1979-06-19 PHENYLPIPERAZINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND USE OF THIS DERIVATIVE IN A PHARMA-CEUTIC PRODUCT. NL7904755A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7818352A FR2429216A1 (en) 1978-06-20 1978-06-20 CNS-active substd. alkyl-meta:tri:fluoro:methyl:thio:phenyl-piperazine - with psychotropic properties, useful in treatment of anxiety and depression
FR7818351A FR2429212A1 (en) 1978-06-20 1978-06-20 PHENYLPIPERAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
NL7904755A true NL7904755A (en) 1979-12-27

Family

ID=26220635

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904755A NL7904755A (en) 1978-06-20 1979-06-19 PHENYLPIPERAZINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND USE OF THIS DERIVATIVE IN A PHARMA-CEUTIC PRODUCT.

Country Status (15)

Country Link
AU (1) AU521110B2 (en)
DE (1) DE2924681A1 (en)
DK (1) DK251079A (en)
ES (1) ES481632A1 (en)
FI (1) FI791926A (en)
GB (1) GB2023594B (en)
GR (1) GR67646B (en)
IL (1) IL57569A0 (en)
IT (1) IT1121588B (en)
LU (1) LU81396A1 (en)
NL (1) NL7904755A (en)
NO (1) NO792020L (en)
NZ (1) NZ190758A (en)
PT (1) PT69775A (en)
SE (1) SE7905402L (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
GB8427125D0 (en) * 1984-10-26 1984-12-05 Lundbeck & Co As H Organic compounds
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
ZA918221B (en) * 1990-10-23 1992-06-24 Akzo Nv 4-(4-or 6-(trifluoromethyl-2-pyridinyl))-1-piperazinyl-alkyl substituted lactams
CA2067475C (en) * 1991-05-08 2000-10-10 Yasuo Oshiro Carbostyril derivatives and their use
IT1251144B (en) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia BENZIMIDAZOLONE DERIVATIVES
EP0913397B1 (en) * 1997-10-22 2006-07-05 Council of Scientific and Industrial Research A proces for the synthesis of 1-(4-Arylpiperazine-1-y1)-3-(2-oxypyrrolidin/piperidin-1-yl)propanes as therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders
EP0911330B1 (en) * 1997-10-22 2007-12-12 Council of Scientific & Industrial Research 1-(4-Arylpiperazine-1-y1)-3-(2-oxopyrrolidin/piperidin-1-y1) propanes as therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
PL1912650T3 (en) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Use of flibanserin in the treatment of obesity
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (en) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Flibanserin for the treatment of urinary incontinence and related diseases
JP5793828B2 (en) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Formulation of flibanserin and method for producing the same
CL2007002214A1 (en) 2006-08-14 2008-03-07 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION IN THE FORM OF COMPRESSED, WHERE AT LEAST THE LENGTH OF THE COMPRESSED IN THE PREVIOUS STATE OF THE APPLICATION IS AT LEAST 7/12 OF THE PILOR DIAMETER OF THE PATIENT AND AFTER INGERING IT IN THE FOOD STATE, THE LENGTH OF THE COMP
EP2056797A2 (en) 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Controlled release system and method for manufacturing the same
CL2008002693A1 (en) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
BRPI1003506B1 (en) 2010-09-24 2019-12-03 Ache Int Bvi Ltd alkyl-piperazine-phenyl-4 (3h) quinazolinone compound and use of the alkyl-piperazine-phenyl-4 (3h) quinazolinone compound associated with 5-ht1a and 5-ht2a serotonergic receptors

Also Published As

Publication number Publication date
GB2023594B (en) 1982-10-13
DE2924681A1 (en) 1980-01-10
AU4811279A (en) 1980-02-07
LU81396A1 (en) 1981-02-03
GR67646B (en) 1981-09-01
NO792020L (en) 1979-12-21
AU521110B2 (en) 1982-03-18
IT7923695A0 (en) 1979-06-18
ES481632A1 (en) 1980-02-16
NZ190758A (en) 1980-10-24
GB2023594A (en) 1980-01-03
IT1121588B (en) 1986-04-02
FI791926A (en) 1979-12-21
SE7905402L (en) 1979-12-21
PT69775A (en) 1979-07-01
IL57569A0 (en) 1979-10-31
DK251079A (en) 1979-12-21

Similar Documents

Publication Publication Date Title
NL7904755A (en) PHENYLPIPERAZINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND USE OF THIS DERIVATIVE IN A PHARMA-CEUTIC PRODUCT.
NL192603B (en) Cosmetic product and method for its preparation.
NL7704057A (en) PROCESS FOR PREPARING NEW CEFOLOSPORIN DERIVATIVES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL182812C (en) METHOD FOR PREPARING POLYURETHANUREA AND FORMED PRODUCT, MANUFACTURED USING THEREOF
NL7705276A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PREPARATIONS OBTAINED ACCORDING TO THIS PROCESS.
NL7903048A (en) METHOD OF PREPARING A MEDICINAL PRODUCT FOR CANCER, THE MEDICINAL PRODUCT THEREFORE CONTAINED AND METHOD OF PREPARING THE MEDICINAL PLATINUM COORDINATION COMPOUNDS.
NL7609414A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING 1-SULFONYLBENZIMIDAZOLE DERIVATIVES.
NL171058C (en) METHOD FOR PREPARING RESPECTIVELY MANUFACTURE OF A PHARMACEUTICAL PREPARATION WITH ANTI-ALLERGIC EFFECT AND METHOD FOR PREPARING USEFUL ALKOXYCHINOLINE DERIVATIVES
NL7704566A (en) PROCESS FOR PREPARING NEW 1,2-DIHYDRONAPHTHALIA ENDERIVATIVES AND PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL7614567A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT AND METHOD OF PREPARING THE MEDICINAL COMPOUND.
IT7925621A0 (en) CEFEM DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
NL188495C (en) PREPARATION OF A PROTEIN FOOD PRODUCT.
NL184684C (en) CHLORINE AMBUCIL DERIVATIVES WITH AN ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A MEDICINAL PRODUCT BASED ON THESE CHLORINE AMBUCIL DERIVATIVES.
NL7903050A (en) METHOD OF PREPARING A MEDICINAL PRODUCT FOR CANCER, THE MEDICINAL PRODUCT THEREFORE, AND METHOD OF PREPARING THE MEDICINAL PLATINUM COMPOUND.
NL7708659A (en) METHOD FOR PREPARING 1-AZOLYL-4-HYDROXYBUTANE DERIVATIVES, AND METHOD FOR PREPARING FUNGICIDES AND BACTERICIDES THEREOF
NL7901787A (en) TWO PHASE PIGMENT AND METHOD FOR PREPARING THIS PIGMENT.
NL7903047A (en) METHOD OF PREPARING A MEDICINAL PRODUCT FOR CANCER, THE MEDICINAL PRODUCT THEREFORE CONTAINED AND METHOD OF PREPARING THE MEDICINAL PLATINUM COORDINATION COMPOUNDS.
NL179053C (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH DERIVATIVE THEREIN.
IT7925069A0 (en) 1-PHTHALAZONE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, AND THEIR USE.
NL7710325A (en) PROCESS FOR THE PREPARATION OF NEW QINOLINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL7902888A (en) MARKED GIBBERLINS OF THEIR DERIVATIVES AND METHOD FOR PREPARING THESE COMPOUNDS.
NL7703824A (en) PROCESS FOR PREPARING NEW PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING PHARMA-CEUTIC PREPARATIONS AND FORMED PHARMA-CEUTIC PREPARATIONS.
NL7902832A (en) SCINTILLOGRAPHIC MEANS AND ITS PREPARATION.
NL7711272A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS, AND FORMED PHARMACEUTICAL PREPARATIONS.
NL161453C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION BASED ON A 1-OXOPYRIMIDO1,2-AŸ-QUINOLINE DERIVATIVE AND PROCESS FOR THE PREPARATION OF 1-OXOPYRIMIDO1,2-AŸQUINOLINE DERIVATIVES.

Legal Events

Date Code Title Description
BV The patent application has lapsed